Belgium· BE-AMP-SAM348284-00
Ibandronate Mylan 150 mg
A ibandronic acid product containing sodium ibandronate monohydrate, registered in Belgium by Viatris GX. The same ATC class is registered in 16 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Ibandronic acid is registered in 16 of 19 countries.
Countries holding a registration under ATC M05BA06 (ibandronic acid), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 10 of them publish a price we can compare per daily dose
Ibandronic acid · ATC M05BA06
16 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ibandronic acid costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.089 in United States to $1.30 in Switzerland — a ×15 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Ibandronic acid · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.30
- ES Spain$0.49
- IT Italy$0.38
- US United States$0.089 (acquisition cost)
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Sodium Ibandronate Monohydrate
- Manufacturer
- Viatris GX
- Country
- Belgium (BE)
- ATC code
- M05BA06
- ATC class
- Ibandronic acid
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb2804086
- be_apb0756312
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
228 interactions on record for ibandronic acid.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ibandronic acid · interactions on record
228 records
- 12 severe
- 98 moderate
- 94 info
Most severe, free to view
- EtelcalcetideH05BX04severe
- SirolimusL01EG04severe
- SirolimusL04AA10severe
- TacrolimusL04AD02severe
24 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ibandronic acid in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBONVIVAAtnahs Pharma Netherlands B.V., Amsterdam
- FinlandBondenzaRoche Registration Limited
- United StatesIbandronate SodiumAurobindo Pharma Limited
- SwedenEtanorden 150 mg Filmdragerad tablettGedeon Richter Plc
- IrelandIbandronic Acid 150 mg film-coated tabletsAccord Healthcare Ireland Ltd.
- IcelandIbandronic acid WHWilliams & Halls ehf
- GermanyAscendraAnwerina Deutschland Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Ibandronsäure +pharma, Ibandronsäure Actavis
- Czechia · Ibandronic Acid Viatris
- Germany · Ascendra, Ibandronsäure Al
- Finland · Ibandronate Ratiopharm
- United Kingdom (Northern Ireland) · Ibandronic Acid Noridem Enterprises
- Greece · Ibondem
- Croatia · Ostea
- Hungary · Bonessa, Etanorden
- Ireland · Ibandronic Acid Noridem Enterprises
- Iceland · Ibandronic Acid Wh
- Italy · Acido Ibandronico Mylan
- Latvia · Ossica
- Netherlands · Ibandroninezuur Synthon
- Poland · Ibandronic Acid Noridem, Osagrand
- Portugal · Ácido Ibandrónico Gedeon Richter
- Romania · Ossica
- Sweden · Ibandronate Bluefish
- Slovakia · Ossica
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8a867e99-e70b-4af0-9c50-d56cbf2204f6 GET /v1/drugs/8a867e99-e70b-4af0-9c50-d56cbf2204f6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Ibandronate Mylan 150 mg",
"name_fr": "Ibandronate Mylan 150 mg",
"name_nl": "Ibandronate Mylan 150 mg",
"amp_code": "SAM348284-00",
"strengths": [
"169.3200",
"169.3200",
"150.0000",
"150.0000"
],
"pack_count": 4,
"substances": [
"Sodium Ibandronate Monohydrate",
"Ibandronic Acid"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Ibandronic Acid",
"authorisation_numbers": [
"BE348284"
]
}See everything about ibandronic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.